[lemma=therefore] [□] □ □
[lemma=therefore] [□=□] □ □
[lemma=therefore] [□ & □] □ □
It will therefore be much more difficult for generic producers to produce copies because they will have to replicate all of the tests performed by the patent holder instead of demonstrating the " bioequivalency " of their product .